Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Denosumab

Hazard - P - B - T - Risk Exempt

Information

Fass environmental information

Fass environmental information for Prolia (denosumab) from Amgen (downloaded 2019-08-19).

Risk

The use of amino acids, proteins and peptides is not considered to have any environmental impact.

According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CHMP/SWP/4447/00) vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids proteins, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment.

Author: The Pharmaceutical unit of Region Stockholm